Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Appointed director
|
|
GENAERA CORP (GENR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2009 |
8-K
| Quarterly results |
| 06/10/2009 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 05/27/2009 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ... |
| 04/29/2009 |
8-K
| Form 8-K -- Current report |
| 04/28/2009 |
8-K
| Entered into consulting agreement |
| 04/03/2009 |
8-K/A
| Form 8-K/A -- Current report [amend] |
| 04/03/2009 |
8-K
| Entered into consulting agreement |
| 03/30/2009 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/10/2009 |
8-K
| Form 8-K -- Current report |
| 03/04/2009 |
8-K
| Form 8-K -- Current report |
| 02/10/2009 |
8-K
| Form 8-K -- Current report |
| 02/05/2009 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Genaera to Present at BIO CEO & Investor Conference Plymouth Meeting, Pa. - February 5, 2009 - Genaera Corporation will present at the Eleventh Annual BIO CEO & Investor Conference, being held February 9-10, at the Waldorf-Astoria Hotel in New York. Jack Armstrong, President and Chief Executive Officer, will provide promising preliminary Phase 1b clinical data for MSI-1436, the first-in-class, highly selective inhibitor of PTP1B and Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity, on Tuesday, February 10, 2009 at 2:15 p.m. . About Genaera Genaera Corporation is developing trodusquemine , for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in ast..." |
|
| 01/22/2009 |
8-K
| Form 8-K -- Current report |
| 12/24/2008 |
8-K
| Form 8-K -- Current report |
| 12/04/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/14/2008 |
8-K
| Quarterly results |
| 11/13/2008 |
8-K
| Form 8-K -- Current report |
| 11/06/2008 |
8-K
| Form 8-K -- Current report |
| 10/31/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/30/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/29/2008 |
8-K
| Form 8-K -- Current report |
| 10/21/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/06/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/28/2008 |
8-K
| Other Events |
| 08/15/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...|
Docs:
|
"Amendment to Letter Agreement, as amended, between the Company and Michael J. Gast, M.D., Ph.D.",
"Amendment to Letter Agreement, as amended, between the Company and Leanne M. Kelly",
"Amendment to Letter Agreement, as amended, between the Company and Henry R. Wolfe, Ph.D.",
"Amendment to the Agreement in the Event of a Change in Control of Genaera Corporation, as amended, between the Company and John L. Armstrong, Jr.",
"Amendment to the Agreement in the Event of a Change in Control of Genaera Corporation, as amended, between the Company and Michael J. Gast, M.D., Ph.D.",
"Amendment to the Agreement in the Event of a Change in Control of Genaera Corporation, as amended, between the Company and Leanne M. Kelly",
"Amendment to the Agreement in the Event of a Change in Control of Genaera Corporation, as amended, between the Company and Henry R. Wolfe, Ph.D.",
"Amendment to the Outstanding Option Grant Agreements between the Company and John L. Armstrong, Jr.",
"Amendment to the Outstanding Option Grant Agreements between the Company and Michael J. Gast, M.D., Ph.D.",
"Amendment to the Outstanding Option Grant Agreements between the Company and Leanne M. Kelly",
"Amendment to the Outstanding Option Grant Agreements between the Company and Henry R. Wolfe, Ph.D." |
|
| 08/14/2008 |
8-K
| Quarterly results |
| 07/25/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/16/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/01/2008 |
8-K
| Appointed a new director |
| 06/16/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/10/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/02/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ... |
| 05/30/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 05/13/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Other Events, Financi... |
|
|
|